MAHWAH, N.J., USA, March 21, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France-based joint replacement company, from Menix.
There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes.
AMSTERDAM--(BUSINESS WIRE)--The first shoulder arthroplasty surgeries using Stryker's Blueprint Mixed Reality Guidance System were successfully completed in Europe.
Das Medizintechnikunternehmen Stryker konnte zum Ende des Jahres 2023 besser als erwartet abschneiden. Auch für 2024 bleibt das Management optimistisch.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.